SI1135153T1 - - Google Patents

Info

Publication number
SI1135153T1
SI1135153T1 SI9930790T SI9930790T SI1135153T1 SI 1135153 T1 SI1135153 T1 SI 1135153T1 SI 9930790 T SI9930790 T SI 9930790T SI 9930790 T SI9930790 T SI 9930790T SI 1135153 T1 SI1135153 T1 SI 1135153T1
Authority
SI
Slovenia
Application number
SI9930790T
Inventor
Michel Aguet
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US1999/027534 external-priority patent/WO2000030673A1/en
Publication of SI1135153T1 publication Critical patent/SI1135153T1/xx

Links

SI9930790T 1998-11-20 1999-11-18 SI1135153T1 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10927598P 1998-11-20 1998-11-20
PCT/US1999/027534 WO2000030673A1 (en) 1998-11-20 1999-11-18 Uses for eph receptor antagonists and agonists to treat vascular disorders
EP99960524A EP1135153B1 (en) 1998-11-20 1999-11-18 Uses for eph receptor antagonists and agonists to treat vascular disorders

Publications (1)

Publication Number Publication Date
SI1135153T1 true SI1135153T1 (cs) 2005-08-31

Family

ID=34066550

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930790T SI1135153T1 (cs) 1998-11-20 1999-11-18

Country Status (2)

Country Link
EP (1) EP1508337A3 (cs)
SI (1) SI1135153T1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1976884T1 (sl) * 2006-01-20 2013-04-30 Genetech, Inc. Anti-efrinB2 protitelesa in postopki uporabe le teh
CA2679986C (en) 2007-03-08 2018-03-06 Martin Lackmann Epha3 antibodies for the treatment of solid tumors
EP2137216A2 (en) * 2007-03-12 2009-12-30 Vasgene Therapeutics, Inc. Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT939809E (pt) * 1996-06-19 2003-08-29 Regeneron Pharma Ligandos do receptor de tie-2 (ligando 3 de tie e ligando 4 de tie) e suas utilizacoes
US6864227B1 (en) * 1998-04-13 2005-03-08 California Institute Of Technology Artery-and vein-specific proteins and uses therefor

Also Published As

Publication number Publication date
EP1508337A2 (en) 2005-02-23
EP1508337A3 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
JP2001523001A5 (cs)
BRPI9917862A2 (cs)
JP2001520395A5 (cs)
JP2002519238A5 (cs)
JP2001516689A5 (cs)
BRPI9816295A2 (cs)
BRPI9917863A2 (cs)
JP2509810C (cs)
JP2569081C (cs)
FR2761124A3 (cs)
IN192393B (cs)
JP2508359Z (cs)
JP2511180C (cs)
JP2545701C (cs)
BY4669C1 (cs)
CN3072873S (cs)
CN3074692S (cs)
CN3074474S (cs)
CN3074158S (cs)
CN3074964S (cs)
BY4408C1 (cs)
CN3074993S (cs)
CN3074054S (cs)
BY6371C1 (cs)
CN3079025S (cs)